학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 41건 | 목록 1~20
Academic Journal
Milhem MM; University of Iowa, Iowa City, Iowa, USA.; Zakharia Y; University of Iowa, Iowa City, Iowa, USA.; Davar D; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.; Buchbinder EI; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Medina T; University of Colorado Denver, Aurora, Colorado, USA.; Daud A; University of California San Francisco, San Francisco, California, USA.; Ribas A; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.; Chmielowski B; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.; Niu J; Banner MD Anderson Cancer Center, Gilbert, Arizona, USA.; Gibney GT; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, USA.; Margolin K; Saint John's Cancer Institute, Santa Monica, California, USA.; Olszanski AJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Mehmi I; The Angeles Clinic and Research Institute, Cedars-Sinai Affiliate, Los Angeles, California, USA.; Sato T; Thomas Jefferson University, Philadelphia, Pennsylvania, USA.; Shaheen M; The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.; Zhao L; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Kelley H; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Liu H; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Kumar S; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Bobilev D; Fusion Pharmaceuticals, Boston, Massachusetts, USA.; Krieg AM; Zola Therapeutics, Needham, Massachusetts, USA.; Wooldridge JE; Checkmate Pharmaceuticals, Cambridge, Massachusetts, USA.; Kirkwood JM; Hillman Cancer Center, University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Academic Journal
Ribas A; University of California, Los Angeles, Los Angeles, California.; Medina T; University of Colorado Cancer Center, Aurora, Colorado.; Kirkwood JM; University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Zakharia Y; University of Iowa, Iowa City, Iowa.; Gonzalez R; University of Colorado Cancer Center, Aurora, Colorado.; Davar D; University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Chmielowski B; University of California, Los Angeles, Los Angeles, California.; Campbell KM; University of California, Los Angeles, Los Angeles, California.; Bao R; University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Kelley H; Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts.; Morris A; Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts.; Mauro D; Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts.; Wooldridge JE; Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts.; Luke JJ; University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.; Weiner GJ; University of Iowa, Iowa City, Iowa.; Krieg AM; Checkmate Pharmaceuticals, Inc., Cambridge, Massachusetts.; Milhem MM; University of Iowa, Iowa City, Iowa.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Badeaux MD; Aeglea BioTherapeutics, Inc., Austin, Texas. mbadeaux@aegleabio.com William.Redmond@providence.org.; Rolig AS; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon.; Agnello G; Aeglea BioTherapeutics, Inc., Austin, Texas.; Enzler D; Aeglea BioTherapeutics, Inc., Austin, Texas.; Kasiewicz MJ; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon.; Priddy L; Aeglea BioTherapeutics, Inc., Austin, Texas.; Wiggins JF; Aeglea BioTherapeutics, Inc., Austin, Texas.; Muir A; The Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Ben May Department for Cancer Research, The University of Chicago, Chicago, Illinois.; Sullivan MR; The Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Van Cleef J; Aeglea BioTherapeutics, Inc., Austin, Texas.; Daige C; Aeglea BioTherapeutics, Inc., Austin, Texas.; Vander Heiden MG; The Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rajamanickam V; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon.; Wooldridge JE; Aeglea BioTherapeutics, Inc., Austin, Texas.; Redmond WL; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon. mbadeaux@aegleabio.com William.Redmond@providence.org.; Rowlinson SW; Aeglea BioTherapeutics, Inc., Austin, Texas.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Academic Journal
Raje NS; Massachusetts General Hospital, Boston, MA, USA.; Moreau P; University Hospital Hôtel-Dieu, Nantes, France.; Terpos E; National and Kapodistrian University of Athens School of Medicine, Athens, Greece.; Benboubker L; Hôpital Bretonneau, Centre Hospitalier Régional Universitaire (CHRU), Tours, France.; Grząśko N; Medical University of Lublin and Department of Haematology, St. John's Cancer Centre, Lublin, Poland.; Holstein SA; Roswell Park Cancer Institute, Buffalo, NY, USA.; Oriol A; Institut Català d'Oncologia (ICO) and Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Hospital Germans Trias i Pujol, Badalona, Spain.; Huang SY; National Taiwan University, Medical College and Hospital, Taipei, Taiwan.; Beksac M; Ankara University Ibn Sina Hospital, Ankara, Turkey.; Kuliczkowski K; Wroclaw Medical University, Wroclaw, Poland.; Tai DF; Eli Lilly and Company, Indianapolis, IN, USA.; Wooldridge JE; Eli Lilly and Company, Indianapolis, IN, USA.; Conti I; Eli Lilly and Company, Indianapolis, IN, USA.; Kaiser CJ; Eli Lilly and Company, Indianapolis, IN, USA.; Nguyen TS; Eli Lilly and Company, Indianapolis, IN, USA.; Cronier DM; Eli Lilly and Company Limited, Windlesham, Surrey, UK.; Palumbo A; Myeloma Unit, Division of Haematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Academic Journal
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Jourdan E; Centre Hospitalier Regional Universitaire de Nîmes , Nîmes , France.; Leblond VMaisonneuve HBenhadji KAHossain AMNguyen TSWooldridge JEMoreau P
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Zent CS; Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA. zent.clive@mayo.edu; Smith BJBallas ZKWooldridge JELink BKCall TGShanafelt TDBowen DAKay NEWitzig TEWeiner GJ
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Karmali R; Rush University Medical Center, Department of Hematology/Oncology, Chicago, IL 60612, USA. reem_karmali@rush.edu; Larson MLWooldridge JEGregory SAO'Brien TShammo JMBueschel KVenugopal P
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Tobinai K; Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.; Ogura MKobayashi YUchida TWatanabe TOyama TMaruyama DSuzuki TMori MKasai MCronier DWooldridge JEKoshiji M
Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE
Editorial & Opinion
Wooldridge JE; Department of Internal Medicine, Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa, Iowa City, USA. wooldridgeje@lilly.com
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print Cited Medium: Print ISSN: 1042-8194 (Print) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Shi H; Department of Pathology and Anatomical Sciences, Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO 65203, USA.; Guo JDuff DJRahmatpanah FChitima-Matsiga RAl-Kuhlani MTaylor KHSjahputera OAndreski MWooldridge JECaldwell CW
Publisher: Irl Press At Oxford University Press Country of Publication: England NLM ID: 8008055 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0143-3334 (Print) Linking ISSN: 01433334 NLM ISO Abbreviation: Carcinogenesis Subsets: MEDLINE
Academic Journal
Chand VK; Department of Internal Medicine, University of Iowa, IA 52242, USA.; Link BKRitchie JMShannon MWooldridge JE
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print Cited Medium: Print ISSN: 1042-8194 (Print) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Wooldridge, James E
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어